[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370460-105":59,"doc-detail-370460-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ajuba-promotes-the-proliferation-invasion-and-migration-of-nsclc-cells-by-activating-the-erk-catenin-pathway","AJUBA promotes the proliferation, invasion and migration of NSCLC cells by activating the ERK/β-catenin pathway","","AJUBA is explored as a potential therapeutic target for non-small cell lung cancer (NSCLC), where its precise role has remained unclear. Immunohistochemistry shows AJUBA upregulation in 67.55% of NSCLC tumors and links it to tumor size, lymph node metastasis, advanced stage, poor differentiation, and poor prognosis. AJUBA knockdown via siAJUBA suppresses proliferation, invasion, and migration in H1299 and A549 cells, inhibits ERK signaling, reduces EMT-related proteins, and decreases p-ERK, β-catenin, and N-cadherin in vivo. Overexpression of AJUBA therefore promotes NSCLC cell proliferation and motility through ERK and Wnt/β-catenin pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ajuba-promotes-the-proliferation-invasion-and-migration-of-nsclc-cells-by-activating-the-erk-catenin-pathway/370460/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ajuba-promotes-the-proliferation-invasion-and-migration-of-nsclc-cells-by-activating-the-erk-catenin-pathway/370460.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How is AJUBA expression related to NSCLC patient outcomes?","Question",{"text":112,"@type":113},"AJUBA expression is upregulated in 67.55% of NSCLC tumor samples and is associated with larger tumors, lymph node metastasis, advanced stage, poor differentiation, and poor prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the effect of AJUBA loss-of-function on NSCLC cells?",{"text":117,"@type":113},"Silencing AJUBA with siRNA significantly inhibits NSCLC cell proliferation, invasion, and migration in the H1299 and A549 cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"Through which signaling pathways does AJUBA promote NSCLC progression?",{"text":121,"@type":113},"AJUBA promotes NSCLC proliferation and motility via ERK signaling and the Wnt/β-catenin pathway, accompanied by reduced EMT-related protein expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370460,1790270768,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAJUBA promotes the proliferation, invasion and migration of NSCLC cells by activating the ERK/β -catenin pathway  \nLianyue Qu1,2, Fan Wang1,4, Yuxiang Wang1,5 & Zixuan Li1,3􀀍  \nAccumulating evidence indicates that AJUBA acts as a potential target for new therapeutics to treat cancers. Nevertheless, the role ofAJUBA in non-small cell lung cancer (NSCLC) remains unclear. In the current study, immunohistochemistry (IHC) showed that expression of AJUBA was upregulated in 67.55% of NSCLC tumor samples and was associated with tumor size, lymph node metastasis, advanced tumor stage, poor differentiation and poor prognosis. Loss-of-function assays ofAJUBA produced by silencing RNA (siAJUBA) significantly inhibited the proliferation, invasion and migration of H1299 andA549 cell lines. Mechanistically, inhibition of extracellular signal-regulated kinases (ERKs) blocked theAJUBA-induced proliferation, invasion and migration of NSCLC cells, and decreased the expression of proteins related to the endothelial-mesenchymal transition (EMT). Silencing of AJUBA repressed tumor growth and led to a decrease in p-ERK, β-catenin and N-cadherin in vivo. In conclusion,, overexpression of AJUBA facilitates the proliferation and motility of NSCLC cells via the ERK andWnt/β-catenin pathways. AJUBA may be useful as a prognostic marker which may provide a promising approach for the treatment of NSCLC.  \nKeywords AJUBA, NSCLC, β-Catenin, P-ERK  \nAbbreviations  \n(si)RNA Silencing RNA  \nTNM Tumor Node Metastasis stage  \nERK Extracellular Signal-Regulated kinases  \nEMT Epithelial-Mesenchymal Transition  \nWTIP Wilms Tumor 1Interacting Protein LIMD1 LIM Domain-Containing Protein 1 CRC Colorectal Cancer  \nESCC Esophageal Squamous Cell Carcinoma HCC Hepatocellular Carcinoma  \nIHC Immunohistochemistry HBE Human Bronchial Epithelial  \nFBS Fetal Calf Serum  \nDMEM Dulbecco’s Modified Eagle’s Medium NC Negative Control  \nPC Plasmid Ccontrol  \nGAPDH Glyceraldehyde-3-Phosphate Dehydrogenase CCK-8 Cell Counting Kit-8  \nMMP-9 Matrix Metalloproteinase-9  \n1Key Laboratory of Diagnostic Imaging and Interventional Radiology of Liaoning Province, Department of Radiology, The First Hospital of China Medical University, Shenyang, P. R. China. 2Department of Pharmacy, The First Hospital of China Medical University, Shenyang, P. R. China. 3Department of Radiology, The First Hospital of China Medical University, Shenyang, P. R. China. 4Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, P. R. China. 5Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, P. R. China. 􀀍 email: [lizx@cmu1h.com](lizx@cmu1h.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nAccording to global cancer statistics, there are more than 2 million newly diagnosed lung cancer patients annually1. Despite intensive efforts to treat non-small cell lung cancer (NSCLC) by developing novel therapeutic strategies, lung cancer has the highest mortality rate among all types of cancer globally2. Therefore, it will be valuable to explore molecular carcinogenesis and facilitate the development of novel therapeutic targets for NSCLC which can prolong the survival of patients. In mammals, the AJUBA family includes three proteins: AJUBA, Wilms tumor 1 interacting protein, and LIM domain-containing protein 1 (LIMD1) . AJUBA, also known as JUB, is located on human chromosome 14 and encodes a protein with a molecular weight of 58 kDa. AJUBA protein is characterized by the presence of three LIM domains at its carboxy terminus, which can assist in its nuclear localization. LIM domains are rich in cysteine and were first discovered in many proteins that regulate cell development. The presence of multiple LIM domains in many proteins implies that AJUBA may bind to them and play a significant role3. AJUBA is present in fetal components of the ","cbCaikvZpFZaoOCh","https://ap.wps.com/l/cbCaikvZpFZaoOCh","pdf",2582745,12,"English","# Background\n## Clinical significance and existing tumor evidence\n## Wnt/β-catenin pathway rationale\n# Study overview and findings","[{\"question\":\"How is AJUBA expression related to NSCLC patient outcomes?\",\"answer\":\"AJUBA expression is upregulated in 67.55% of NSCLC tumor samples and is associated with larger tumors, lymph node metastasis, advanced stage, poor differentiation, and poor prognosis.\"},{\"question\":\"What is the effect of AJUBA loss-of-function on NSCLC cells?\",\"answer\":\"Silencing AJUBA with siRNA significantly inhibits NSCLC cell proliferation, invasion, and migration in the H1299 and A549 cell lines.\"},{\"question\":\"Through which signaling pathways does AJUBA promote NSCLC progression?\",\"answer\":\"AJUBA promotes NSCLC proliferation and motility via ERK signaling and the Wnt/β-catenin pathway, accompanied by reduced EMT-related protein expression.\"}]","AJUBA promotes the proliferation, invasion and migration of NSCLC cells by activating the ERK/β-catenin pathway | PDF",1790188655,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9729f2318fdb6088881d478315500967.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ec6abb82b0199bafd630205d065fbcd.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8664b3156407e2ac32191ca005502f8.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d3c0300ae96b2f3f7baa9df358083b4.webp",980,1287]